Adapting psychotherapy in collaborative care for treating opioid use disorder and co-occurring psychiatric conditions in primary care.
Adapting psychotherapy in collaborative care for treating opioid use disorder and co-occurring psychiatric conditions in primary care.
复制标题
在协作护理中采用心理治疗,治疗阿片类药物使用障碍和初级护理中并发的精神疾病。
DOI:
10.1037/fsh0000791
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Newman,
中科院分区:
文献类型:
--
作者:
French,Rachel;Worley,Julie;Lowenstein,Margaret;Bogner,HillaryR;Calderbank,Tara;DePhilippis,Dominick;Forrest,Andrew;ConnollyGibbons,MaryBeth;Harris,RebeccaArden;Heywood,Saida;Kampman,Kyle;Mandell,DavidS;McKay,JamesR;Newman,
IntroductionOpioid use disorder (OUD) and psychiatric conditions commonly co-occur yet are infrequently treated with evidence-based therapeutic approaches, resulting in poor outcomes. These conditions, separately, present challenges to treatment initiation, retention, and success. These challenges are compounded when individuals have OUD and psychiatric conditions.MethodRecognizing the complex needs of these individuals, gaps in care, and the potential for primary care to bridge these gaps, we developed a psychotherapy program that integrates brief, evidence-based psychotherapies for substance use, depression, and anxiety, building on traditional elements of the Collaborative Care Model (CoCM). In this article, we describe this psychotherapy program in a primary care setting as part of a compendium of collaborative services.ResultsPatients receive up to 12 sessions of evidence-based psychotherapy and case management based on a structured treatment manual that guides treatment via Motivational Enhancement; Cognitive Behavioral Therapies for depression, anxiety, and/or substance use disorder; and/or Behavioral Activation components.DiscussionNovel, integrated treatments are needed to advance service delivery for individuals with OUD and psychiatric conditions and these programs must be rigorously evaluated. We describe our team’s efforts to test our psychotherapy program in a large primary care network as part of an ongoing three-arm randomized controlled trial.(PsycInfo Database Record (c) 2023 APA, all rights reserved)